Oculis Holding AG (OCS) Return on Assets (2023 - 2026)
Quarterly Return on Assets rose 59.0% to 0.69% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.69% through Mar 2026, up 59.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
Oculis Holding AG's Return on Assets history spans 4 years, with the latest figure at 0.69% for Q1 2026.
- Return on Assets came in at 0.69% for Q1 2026, up from 0.83% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2024 to a low of 1.65% in Q4 2024.
- The 4-year median for Return on Assets is 0.83% (2025), against an average of 0.73%.
- Year-over-year, Return on Assets plummeted -165bps in 2024 and then soared 82bps in 2025.
- Oculis Holding AG's Return on Assets stood at 0.01% in 2023, then crashed by -23167bps to 1.65% in 2024, then skyrocketed by 50bps to 0.83% in 2025, then increased by 17bps to 0.69% in 2026.
- Per Business Quant, the three most recent readings for OCS's Return on Assets are 0.69% (Q1 2026), 0.83% (Q4 2025), and 0.99% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.00% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.00% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.00% |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -0.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.69% |
| Dec 31, 2025 | -0.83% |
| Sep 30, 2025 | -0.99% |
| Jun 30, 2025 | -1.05% |
| Mar 31, 2025 | -1.28% |
| Dec 31, 2024 | -1.65% |
| Sep 30, 2024 | -1.56% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |